In addition to facilitating centralized scanning for a variety of imaging, the TechLive system may help ease the strain of technologist shortages and broaden access to advanced imaging exams.
The Food and Drug Administration (FDA) has granted 510(k) clearance for TechLive™ (DeepHealth/RadNet), a remote scanning platform that enables off-site oversight of magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET)/CT and ultrasound procedures.
Noting ongoing challenges with technologist shortages, DeepHealth said TechLive allows technologists to handle scanning for multiple locations. The company maintained that TechLive can improve access for complex imaging procedures and facilitate expanded hours for imaging facilities.
TechLive™ (DeepHealth/RadNet), a remote scanning platform that enables off-site oversight of magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET)/CT and ultrasound procedures, recently garnered 510(k) clearance from the FDA. (Image courtesy of DeepHealth.)
A recent pilot deployment of TechLive led to a 42 percent decrease of MRI room closure hours, according to DeepHealth.
By offering remote scanning capabilities for ultrasound exams, DeepHealth pointed out that TechLive enables experienced sonographers to guide on-site technologists through complex cases.
“By enabling real-time remote expertise, we are not only addressing today’s staffing challenges, we are creating a foundation for more efficient, financially sustainable, and high-quality patient care across the broadest set of imaging modalities,” noted Sham Sokka, Ph.D., the chief operating and technology officer for DeepHealth. “This FDA clearance validates DeepHealth’s vision of a connected imaging ecosystem that scales human expertise beyond physical boundaries.”
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.